FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 361:8-9 July 2, 2009 Number 1 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

As Congress continues to discuss the reform of physician–industry relations, individual states are enacting new laws. In July 2009, regulations on the conduct of pharmaceutical and medical-device manufacturers take effect in Massachusetts,¹ as does a Vermont law on the marketing of prescribed products.²

The Vermont law, signed on June 8, 2009, by Governor Jim Douglas, a Republican, is broader and stricter than the 2008 Massachusetts law, which had previously been considered the most comprehensive in the country. Vermont's law bans gifts to physicians from manufacturers of prescription drugs, medical devices, and biologic products, with few exceptions. For the gifts and . . . [Full Text of this Article]

Source Information

Dr. Steinbrook (rsteinbrook@attglobal.net) is a national correspondent for the Journal.

This article (10.1056/NEJMp0904719) was published on June 10, 2009, at NEJM.org.

This article has been cited by other articles:

• (2009). All you need to read in the other general journals. BMJ 339: b2709-b2709 [Full Text]